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 9 
(ABSTRACT) 10 
The phenomenon of ion mobility (IM), the movement/transport of charged particles under the 11 
influence of an electric field, was first observed in the early twentieth Century and harnessed later in 12 
ion mobility spectrometry (IMS). There have been rapid advances in instrumental design, 13 
experimental methods and theory together with contributions from computational chemistry and gas-14 
phase ion chemistry which have diversified the range of potential applications of contemporary IMS 15 
techniques. Whilst IMS-mass spectrometry (IMS-MS) has recently been recognized for having 16 
significant research/applied industrial potential and encompasses multi-/cross-disciplinary areas of 17 
science, the applications and impact from decades of research are only now beginning to be utilised 18 
for ‘small molecule’ species. This review focuses on the application of IMS-MS to ‘small molecule’ 19 
species typically used in drug discovery (from 100 to 500 Da) including an assessment of the 20 
limitations and possibilities of the technique. Potential future developments in instrumental design, 21 
experimental methods and applications are addressed.  22 
 23 
The typical application of IMS-MS in relation to small molecules has been to separate species in fairly 24 
uniform molecular classes such as mixture analysis, including metabolites. Separation of similar 25 
species has historically been challenging using IMS as the resolving power, R, has been low (from 3-26 
100) and the differences in collision cross-sections that could be measured have been relatively small, 27 
so instrument and method development has often focused on increasing resolving power. However, 28 
IMS-MS has a range of other potential applications that are examined in this review where it displays 29 
unique advantages, including: determination of small molecule structure from drift time, ‘small 30 
molecule’ separation in achiral and chiral mixtures, improvement in selectivity, identification of 31 
carbohydrate isomers, metabonomics, and for understanding the size and shape of small molecules. 32 
This review provides a broad but selective overview of current literature, concentrating on IMS-MS, 33 
not solely IMS, and small molecule applications. 34 
 35 
Keywords: ion-mobility mass spectrometry; ion mobility spectrometry; mass spectrometry; small 36 
molecule; mass-mobility correlation; collision cross-section; ion mobility; FAIMS; drift-time; travelling 37 
wave; structural; computational; differential mobility spectrometry; differential mobility analyzer 38 
 39 
I. INTRODUCTION TO IMS 40 
The existence of ions in the gas-phase was first discovered when investigating changes in the 41 
electrical conductance of air (Thomson, 1903) which had previously been thought to be an electrical 42 
insulator. Further work established the generation of ions by UV and X-ray from work by Thomson and 43 
Rutherford (1896), Roentgen (1896) and Rutherford (1897)). The rudimentary scientific tools available 44 
at the time did not allow a comprehensive understanding of ion behaviour but the behaviour of simple 45 
gas-phase ions in a weak electric field was further elucidated by Langevin (1905), who demonstrated 46 
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that air was a mixture of gases and developed models that described these simpler systems 47 
remarkably well.  48 
 49 
Thomson and Aston later developed the first mass spectrometer (Aston, 1919) and further research 50 
focussed on low pressure studies of ion-molecule systems that, although not directly involving typical 51 
ion mobility pressure regimes, accrued knowledge in the behaviour of ion motion in a partial vacuum.  52 
 53 
The rapid uptake of IMS in military and forensic applications (Zolotov, 2006) benefited from the 54 
relatively high proton affinity of the analytes (chemical warfare agents, explosives and illicit drugs), 55 
low detection limits and miniaturisation of IMS instrumentation. IMS instrumentation was re-designed 56 
for the field, used internal calibrant standards and simplified user interfaces allowed their use by non-57 
scientist military and security personnel. IMS instrumentation is now ubiquitous in handheld forensics, 58 
cleaning validation and military applications (from border control to explosive testing in war zones).  59 
 60 
Separation in IMS occurs rapidly, in milliseconds, rather than seconds as in chromatography, so IMS 61 
is now beginning to be recognised as a powerful separation step which can be utilised post-ionisation 62 
using a range of equipment, benefits from robust day-to-day operation and allows size and shape 63 
separation and measurement of analytes that cannot easily be derived using other techniques. 64 
Miniaturisation, demonstrated so far primarily in overtone IMS and microfabricated Field Asymmetric 65 
IMS (FAIMS), is a highly attractive feature and IMS typically has a low detection limit of nanograms 66 
and does not require expensive and environmentally damaging solvents.  67 
II. INTRODUCTION TO IMS-MS 68 
The most important aspect of the combination of an IMS separation (typically occurring in the 69 
millisecond time-frame) and MS detection (typically occuring in the microsecond time-frame) is that it 70 
allows an additional separation step to be obtained on a MS time-frame (e.g. in addition to liquid 71 
chromatography), without compromising the speed of MS detection. 72 
 73 
The work of McDaniel and Martin (1960), Kebarle (1965) and Hogg (1965), Albritton et al., (1968) and 74 
later Crompton and Milloy (1977) developed the recognizable configuration of linear drift-tube IMS 75 
(DT-IMS). The combination of ion mobility and mass spectrometry allowed more complex studies to 76 
be conducted in order to develop models of ion mobility. 77 
 78 
IMS was first hyphenated to a mass spectrometer by Barnes, McDaniel and Martin (1961) using a 79 
magnetic sector mass spectrometer; subsequently McAffee and Edelson (1963) described 80 
hyphenation to a time-of-flight (TOF) MS. The coupling of IMS with a TOF mass spectrometer is 81 
particularly appropriate because the TOF mass spectrometer has the fastest data acquisition rate of 82 
any mass spectrometer and can acquire many spectra on the microsecond scale whilst the IMS 83 
analytes arrive on a millisecond timescale.  84 
 85 
A review by Hill et al. (2007) describes the early development of IMS-MS with significant contributions 86 
and discoveries including those from Bowers, Kemper, Clemmer and Kebarle. IMS has since been 87 
interfaced to quadrupole mass spectrometers (Karasek et al., 1976; Wu et al., 1998), quadrupole ion 88 
traps (Creaser et al., 2000), linear ion traps and Fourier-transform ion cyclotron mass spectrometers 89 
(Bluhm et al., 2000) which is beneficial in terms of a wider linear dynamic range and increased mass 90 
spectral resolution. Clemmer et al., (1997) and Creaser et al., (2000) also reversed the stages to 91 
produce a MS-IMS design that traps and stores ions in an initial quadrupole ion trap for subsequent 92 
ion mobility measurements which has the advantage of pre-concentrating low abundant components.  93 
 94 
Recently IMS has been hyphenated to mass spectrometry systems and the availability of 95 
commercially supported instrumentation has arguably led to a rapid increase in the number of 96 
publications on IMS-MS, as shown in FIGURE 1. FAIMS, a type of differential mobility spectrometry, 97 
originated in Russia in the early 1980s (Gorshkov, 1982) emerged as an analytical tool (Buryakov et 98 
al., 1993), and was later commercialised by Ionalytics  (Selectra, 2003), as a front-end accessory for 99 
MDS Sciex (Concord, Ontario, Canada) mass spectrometer systems (2004), Thermo FAIMS, (2007) 100 
and Owlstone Nanotechnologies FAIMS. Waters Inc. (Milford, MA) launched the first generation Synapt 101 
Triwave travelling wave IMS system in 2006 and updated with a second generation instrument with 102 
improved resolution (G2, 2009) and improvements to sensitivity (G2S, 2011). AB Sciex launched the 103 
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SelexION ion mobility device in 2011 for their triple quadrupole mass spectrometer and quadrupole-104 
trap mass spectrometer.  105 
 106 
 107 
FIGURE 1.  Chart showing number of publications containing the phrases “ion mobility” and “ion 108 
mobility mass spectrometry” obtained using CAS Scifinder. 109 
 110 
There has been limited recognition of the potential of IMS-MS analysis for ‘rule-of-5’ type small-111 
molecules (Lipinski et al., 1997) outside of traditional IMS analyte classes (e.g. explosives, chemical 112 
warfare and illicit drugs). The historical lack of interest and sporadic periods of development in IMS-113 
MS for small molecule applications seems most likely to be due to perceived poor resolution, 114 
strengths in competing chromatographic techniques and weaknesses in the robustness of IMS 115 
regarding a poor linear range (Turner and Brokenshire, 1994), “memory effects” from contamination 116 
(Gehrke, 2001) and interference from matrices.  117 
 118 
In contrast IMS-MS has been applied to biomolecules including peptides (Harvey, Macphee & Barran , 119 
2011), proteins (60 kDa-150 kDa) and large protein complexes (1- 4 MDa) (Uetrecht et al., 2010) 120 
particularly after the application of non-covalent mass spectrometry conditions to IMS-MS. Using 121 
these especially gentle electrospray ionisation conditions is believed to maintain the weak 122 
(cooperative) molecular interactions present in many biomolecular structures and thus avoid 123 
fragmentation. Whilst IMS-MS typically lacks the resolution (1% error or 10 nm2) of x-ray or NMR for 124 
large molecular weight biomolecules it enables analysis using smaller amount of material, allows 125 
analysis of structures >100 kDa that are difficult to analyse by NMR and is, arguably, as realistic an 126 
environment as x-ray structures due to lattice effects present. IMS-MS has, therefore, been utilised as 127 
a tool to probe the stabilisation of proteins in the presence of ligands and metals (as a unique method 128 
of metal speciation; Souza Pessôa et al., 2011), protein-protein-interactions, protein mutants and their 129 
structural consequences as well as protein unfolding via various means of ion activation (Jurneczko 130 
and Barran, 2011). In addition to detailed understanding of individual biomolecular systems, IMS-MS 131 
has also been applied to more high-throughput analytical approaches including screening of 132 
phosphorylated peptides (Thalassinos et al., 2009), identification and separation of chemically cross-133 
linked peptides (Santos et al., 2010) and combining topology in protein substructures with proteomics 134 
data (Zhou and Robinson, 2010). This review does not attempt to summarise biomolecule analysis by 135 
IMS-MS, which is covered by many authors, but rather to contrast the adoption of IMS-MS in 136 
biomolecule analysis and focuses on small molecule applications. 137 
III. DIFFERENCES IN PERFORMANCE OF IMS-MS AND IMS  138 
A. The ion efficiency and resolution challenge 139 
Some of the key differences between IMS and hyphenated IMS-MS include the pressure regime in 140 
the ion mobility cell, the size of the instrument and the typical ionisation source. Whilst specifications 141 
and performance in IMS may be indicative of those in IMS-MS there are some technical reasons why 142 
this may not follow. It is critical to note that the results may well be different in IMS-MS compared to 143 
IMS especially due to sensitivity issues and pressure regime changes from IMS to MS stages. 144 
 145 
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In IMS-MS there are often two main challenges (i) to utilise all the ions from the ionisation source, 146 
(especially in a pulsed IMS separation such as drift-time IMS, but not a challenge in DMS or FAIMS 147 
which typically have a 100% duty cycle if a single transmission voltage is selected) and (ii) elimination 148 
of all neutral species whilst ensuring transmission of ions to the MS stages to maintain sensitivity. 149 
Traditionally DT-IMS-MS sensitivity has been estimated to be inversely proportional to the IMS 150 
resolving power squared; ion losses at the IMS exit aperture ranging from 99 to 99.9% (Tang et al., 151 
2005) and ion introduction losses being between 99.6 to 99.9% (Belov et al., 2008). The desire to 152 
increase the gas pressure in the DT-IMS cell to increase resolution must therefore be balanced with 153 
the possibility that it may well reduce ion transmission by requiring a reduction of the aperture size in 154 
the interface from IMS to MS. The different pressure regimes in IMS systems are described in Table 1. 155 
 156 
For DT-IMS-MS the drift gas pressure must be increased proportionally to electric field strength in 157 
order to maintain a low E/N ratio (<2 x 10-17 Vcm2), required to obtain field-independent mobilities for 158 
which the simplified Mason-Schamp equation (Mason and McDaniel, 1988) holds:  159 
 160 
      161 
   (1)  162 
    163 
  164 
Where K is the ion mobility, q is the ionic charge, N is the buffer gas density,  is the reduced mass 165 
of the buffer gas and the ion, k is the Boltzman constant, T is the temperature and Ω is the collision 166 
cross-section (CCS). 167 
 168 
For Travelling Wave Ion Mobility-MS (TWIMS-MS) the gas pressure must also be increased 169 
proportionally to the electric field, such that: 170 
 171 
 172 
    
  
173 
 (2)  174 
 175 
where K  is the ion mobility, N  is the buffer gas density, oN  is the Loschmidt number (the value of N 176 
at standard temperature ( oT  = 273K) and pressure ( P = 1 Atm) and Ko is the reduced ion mobility.  177 
 178 
TABLE 1. Pressure regimes in typical IMS systems. 179 
 180 
Type of IMS system Pressure regime Typical operating pressure 
Ambient DT-IMS Ambient pressure 1000 mbar (Kanu et al., 2008) 
Reduced pressure DT-IMS Reduced pressure 10-5 (Ruotolo et al., 2002b) to 1.3 (Valentine et 
al., 2001) mbar 
 
FAIMS or DMS Ambient pressure-
>ambient pressure 
400 to 1571 mbar (Kolakowski and Mester, 2007)  
Travelling wave IMS Reduced pressure 0.5 mbar (Waters Synapt G1)  to >3 mbar 
(Waters Synapt G2) (Giles et al., 2011) 
Differential mobility 
analysis 
Ambient pressure 1013 mbar 
 181 
Approaches to maximise sensitivity include utilising quadrupole and octopole ion traps (Henderson et 182 
al., 1999;Creaser et al., 2000; Myung et al., 2003) and electrodynamic ion funnels (Wyttenbach et al., 183 
2001) to accumulate and introduce ions efficiently from the ion source to increase the sensitivity of 184 
DT-IMS.  Multiplexing approaches including Hadamard (Clowers et al., 2006) and Fourier-type (Tarver, 185 
2004) gating techniques have also been utilised for increasing the sensitivity of DTIMS, by increasing 186 
the frequency of ion injection events and thus increasing the quantity of ions injected into DT-IMS by 187 
up to 50%. Most of these approaches have been integrated into full IMS-MS systems with dramatic 188 
improvements in sensitivity.  189 
 190 
There is some uncertainty in the identification of the ions in their transmission through the IM cell and 191 
it seems clear that hyphenating IMS and MS allows a more comprehensive understanding of the 192 
 /1)/2)(16/3( 21kTNqK 
)/(/ oooo PTTKPNNKK 
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ionisation processes and fragmentation pathways in IMS.  For example, when using a radioactive 63Ni 193 
cell, proton transfer to the analytes should lead to protonated monomer and dimer ions; however, 194 
without a mass spectrometer as the detector, the identification of the ions in the ion cell cannot be 195 
unambiguously ascertained. Indeed, a comparison of limonene and 2-nonanone by IMS and IMS-MS 196 
resulted in a variety of unexpected fragments and ions, resulting in a non-trivial IMS spectrum and 197 
making interpretation of the results difficult (Vautz et al., 2010). Any unambiguous identification of ions 198 
in IMS will be important both in structural measurements (size, shape and topology) and for 199 
comparison of related IMS techniques (e.g. TWIMS-MS) that often use historical DT-IMS-MS data as 200 
calibration standards in ion mobility and collision cross-section calculations.  201 
B. Features of IMS techniques utilised in IMS-MS 202 
IMS-MS potentially provides a number of advantages over and above IMS including: 203 
i) as a rapid gas-phase separation step before mass spectrometryanalysis,  204 
ii) the identification of ions subsequent to characteristic drift times by comparison with data 205 
acquired under comparable conditions,  206 
iii) measurements of collision cross-sections and derivation of further information about size and 207 
shape, either by comparison with computational modeling or by analysis within a series of 208 
compounds 209 
iv) better characterisation of ion and ion-neutral ion mobilities by simultaneous acquisition of 210 
mass spectrometry data, and 211 
v) better characterisation of ionisation (Tang et al., 2006) and fragmentation pathways via a 212 
better understanding of gas-phase ion structures 213 
 214 
IMS has been hyphenated to liquid chromatography, gas chromatography (Baim and Hill, 1982; 215 
Snyder et al., 1993), super-critical fluid chromatography (Eatherton et al., 1986; Huang et al., 1991), 216 
ions produced via matrix assisted laser desorption ionisation (Jackson et al., 2007), desorption 217 
electrospray ionisation (Weston et al., 2005), pulsed corona discharge ionisation (Hill and Thomas, 218 
2003) and miniaturised to microchip scale (Shvartsburg et al., 2009b). 219 
 220 
IMS-MS systems are typically composed of four stages (Figure 2): 221 
1) an ion source e.g. MALDI or electrospray that generates ions. Electrospray ion sources have 222 
been preferred for retaining native-like structures in biological systems.  223 
2) an IMS cell, where charged particles migrate under the influence of an electric field. 224 
3) a mass analyzer, typically a time-of-flight (TOF) mass spectrometer which is designed to 225 
allow a fast acquisition rate and large mass detection range. 226 
4) an ion detector. 227 
 228 
 229 
FIGURE 2.  Overview of typical ion-mobility mass spectrometer configurations, adapted from Enders 230 
and Mclean, 2009. 231 
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There are four main types of IM cell utilised in IMS-MS. 232 
(i) Drift-time IMS (DT-IMS) is the simplest configuration where collision cross-section (CCS) can 233 
be directly calculated without calibration and provides the highest resolving power. A tube is 234 
filled with a buffer gas (or mixture) and a low voltage field is applied, typically from 5 to 100 235 
Vcm-1. The ions collide with neutral buffer gas molecules, exit via a detector and the collision 236 
cross-section ΩT, at a temperature T can be obtained by measuring the velocity of the ions 237 
and solving the Mason-Schamp equations at intermediate electrical fields (5-100 Vcm-1): 238 
 239 
 (3) 
 240 
 241 
where dV  is the drift velocity of the ion, K is the ion mobility, E is the imposed electric field, 242 
and 243 
 
244 
 (4)
 245 
 246 
where z is the numerical charge, e is the elementary charge, N  is the number density of the 247 
buffer gas,   is the reduced mass of the ion- buffer gas neutral pair, k  is the Boltzmann 248 
constant and T  the temperature in Kelvin. 249 
 250 
DT-IMS suffers from an inherent lack of sensitivity, due to a pulsed analysis (where ions are 251 
measured in packets), and the subsequent loss in duty cycle, as the time between packets of 252 
ions is not utilised. A review of IMS by Eiceman and Karpas (2004) discusses the history of 253 
IMS, the chemistry and physics of ion behaviour and reflects on the potential future 254 
development and applications of IMS. 255 
 256 
In linear DT-IMS, illustrated in FIGURE 3, the sample is introduced to an ionisation region 257 
where ionisation can take place by a number of methods including ȕ-emission from a 63Ni 258 
corona discharge, photo-ionisation, electrospray etc. Ions are allowed through an electric 259 
shutter grid, whilst neutrals remain in the ionisation source and the measurement time is 260 
initiated. The drift tube can vary in length from 5 centimetres to 3 metres or more. An electric 261 
field gradient, typically from 10-100 Vcm-1, from the ionisation source to the detector causes 262 
the ions to traverse the drift tube at a constant velocity.  A drift gas is introduced counter-263 
current to the flow of ions keeping the drift-tube free of neutrals which could participate in ion-264 
neutral clusters.  265 
 266 
 267 
 268 
 269 
FIGURE 3.  Illustration of DT-IMS, adapted from Eiceman and Karpas (2004).  A voltage 270 
gradient is applied to the ions from left to right.  271 
 272 
The total ion signal is detected and plotted with respect to time to form an ion mobility 273 
spectrum, e.g. (see FIGURE 4) for a mixture of amphetamines analysed by ESI-DT-IMS-MS 274 
(Matz and Hill, 2002). Smaller ions travel faster through the drift region and have shorter drift 275 
times, compared to higher molecular weight ions that drift slower and possess longer drift 276 
times.  277 
 278 
Drift region Ionization region Detector 
KEdV 
 KkTNzeT 1
212
16
3 
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 279 
FIGURE 4.  ESI-DT-IMS-MS spectrum of a mixture of 1) amphetamine, 2) methamphetamine,                           280 
3) ethylamphetamine, 4) 3,4-methyldioxyamphetamine, 5) 3,4-methylenedioxy methamphetamine and 281 
6) 3,4-methylenedioxyethylamphetamine, adapted from Matz and Hill (2002a). 282 
Another complementary approach to classical DT-IMS-MS was the use of the second quadrupole 283 
(Figure 5) in a triple-quadrupole mass spectrometer as an ion mobility device; while this approach 284 
was never commercialized it did open up opportunities in hyphenation of IMS and MS. In the triple 285 
quadrupole energy loss method an incident ion is transmitted to the second quadrupole of a triple 286 
quadrupole mass spectrometer where the ion will experience a drag coefficient and generate a 287 
stopping curve; from the stopping curve the ion mobility can be measured and a collision             288 
cross-section determined. Indeed, Covey and Douglas (1993) were the first to measure collision 289 
cross- sections for some biomolecules using this method and also later reviewed collision dynamics in 290 
quadrupole systems including an assessment of the internal energy of the C6H5+ ion by measuring the 291 
increase in collision cross-section after collisional activation (Douglas, 1998) .  292 
 293 
FIGURE 5.  Schematic of the triple quadrupole configuration that can be used to obtain ion mobility 294 
measurements via an energy loss method, adapted from Purves et al. (2000). 295 
This triple-quadrupole energy loss method was further developed to utilise segmented collision cell 296 
rods separated by small 1 mm gaps that enabled a radio-frequency only quadrupole drift cell to be 297 
used to reduce ion losses due to diffusion and enable mass selection before or after the drift cell, and 298 
a DC gradient that moved the ions in an axial direction (see Figure 6, Javahery & Thomson, 1997).  299 
Unfortunately this configuration was outside the typical low-field IMS range and may have resulted in 300 
field-heating of ions. This configuration was later improved to possess an increased gas pressure and 301 
lower field concentration that resulted in minimal internal excitation of the ions (Guo et al. 2004). 302 
 303 
 304 
 305 
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 306 
 307 
 308 
 309 
FIGURE 6.  Schematic of a segmented triple quadrupole configuration that can be used to obtain ion 310 
mobility measurements, adapted from Javahery & Thomson (1997). 311 
 312 
(ii) Differential mobility IMS (DMS) or FAIMS uses a sequence of intermediate and high field 313 
regimes where the behaviour of ions is described empirically by the Mason-Schamp equation 314 
(Mason and McDaniel, 1988) under a high-field regime, which can be expanded to an infinite 315 
series of NE / : 316 
 317 
    (5) 318 
 319 
 320 
where 0K is the reduced ion mobility, E is the field intensity and N is the buffer gas number 321 
density. However, under a typical FAIMS electric field the mobility can be approximated by 322 
using the first two factors as the importance of the sixth order and higher are insignificant  (the 323 
fourth order is two orders of magnitude smaller than second order,
 
and the second order is 324 
three to five orders of magnitude smaller than one (see Shvartsburg et al., 2004). 325 
 326 
The basic principle of operation is that ions are introduced to a region with electrodes and a 327 
stream of gas acts as a transport medium. An asymmetric waveform is passed across the 328 
electrodes, which consists of a high potential electric field for a short time followed by a low 329 
potential electric field for a longer time; this typically fixed dispersion voltage (DV) waveform is 330 
superimposed with a variable compensation voltage (CV) to maintain a stable trajectory for 331 
the analyte ion. This process will effectively select ions and act as an ion filter, as shown in 332 
Figure 7. A cylindrical electrode configuration has usually been designated FAIMS, whereas 333 
parallel plate configurations have typically been designated as DMS.   334 
 335 
........))/()/()/(1()( 64200  NEcNEbNEaKEK
 Page 9 of 45 
 
 336 
FIGURE 7.  Illustration of an example of a parallel plate DMS with compensation voltage applied 337 
showing ion transmission, adapted from Thermo Fisher Scientific Inc., FAIMS Operators manual 338 
(2007). 339 
 340 
A compensation voltage scan measurement (Figure 8) shows a typical profile attained by 341 
optimising the effect of inner and outer electrode temperatures on peak profile for morphine 342 
and its 3-ȕ-D-glucuronide metabolite (Hatsis et al., 2007). Optimising the separation of 343 
morphine whilst maintaining sensitivity was reported to enable the metabolite interference to 344 
be effectively filtered out, and significantly improve the quantification of morphine.  345 
 346 
FIGURE 8.  Compensation voltage scans of morphine and the glucoronide metabolite, adapted from 347 
Hatsis et al., (2007). 348 
 349 
The use of compensation voltage optimisation to select an analyte ion can result in a clear difference 350 
in the mass spectrum observed resulting in an increased S:N ratio for the analyte and a reduction in 351 
other signals as shown in the use of ESI-FAIMS-MS with cisplatin and its hydrolysis products (Cui et 352 
al., 2003) shown in FIGURE 9. 353 
 354 
DV 
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 355 
FIGURE 9.  Mass spectra showing the reduction in background noise from (a) ESI-MS to (b) ESI-356 
FAIMS-MS, adapted from Cui et al. (2003).  357 
Currently the factors determining the separation mechanism in FAIMS or DMS and factors 358 
governing peak width as well as transmission remain relatively difficult to predict (Shvartsburg 359 
et al., 2004). The parameters influencing performance include field intensity, ion path length, 360 
gas properties (composition, temperature, pressure), shape and width of electrodes, the 361 
profile and frequency of asymmetric waveform, compensation voltage scan speed and gas 362 
flow. Champarnaud et al., (2009) studied the separation of trace level impurities by combining 363 
experimental observation with a Design of Experiment (DOE) statistical treatment that 364 
indicated important factors in the optimisation of the values of the compensation voltage, 365 
signal intensity, separation, peak asymmetry and peak width. However, a study of 366 
tetraalkylammonium ions found standard conditions were often suitable for selecting ions with 367 
an m/z value of 100-700 (Aksenov and Kapron, 2010). The simulation of ion motion in planar 368 
electrode FAIMS and cylindrical electrode FAIMS, provided insights into design, experimental 369 
variables and interpretation (Smith et al., 2009b) and some of the key molecular and 370 
instrumental parameters affecting performance were discussed by Nazarov (2006) and Levin 371 
et al. (2004).  372 
 373 
Whilst there are several novel geometries (Prieto, 2011), there are two main forms of field 374 
asymmetrical waveform ion mobility spectrometers: 1) those with planar electrode geometry 375 
and 2) those with curved electrode geometry. Both planar geometry and the curved 376 
geometries of FAIMS and DMS evolved during the 1990s, and in the early 1990s the term 377 
differential mobility spectrometry (DMS) became generally synonymous with planar 378 
electrodes and the term FAIMS became synonymous with curved geometries, although there 379 
are multiple examples of overlapping usage of the terms DMS and FAIMS. One of the primary 380 
differences relates to the use of polar transport gas modifiers. Planar devices create 381 
homogeneous electric fields which enables the use of transport gas modifiers without 382 
resolution losses whereas curved geometries tend to create inhomogeneous fields which lead 383 
to a loss in resolution when using transport gas modifiers. However, curved geometries have 384 
been shown to provide some degree of ion focusing at atmospheric pressure resulting in 385 
higher sensitivity (Guevremont & Purves, 1999; Krylov, 1999). Planar line-of-sight analyzers 386 
enjoy the convenience of transmitting all ions when the RF voltages are turned off, so that 387 
operation without mobility separation can be achieved simply by turning off the fields. Curved 388 
geometry/non line-of-sight FAIMS require the device to be removed for operation without 389 
mobility separation. A wider analysis of the differences between alternative geometries was 390 
described by Krylov (2003). 391 
 392 
A comprehensive review discussed the applications of FAIMS for drinking water analysis, 393 
pharmaceutical metabolite identification and separation of isomers and isobaric peaks 394 
(Kolakowski and Mester, 2007). In addition a detailed account of the fundamentals of DMS 395 
and FAIMS has been written by Shvartsburg (Shvartsburg, 2010).  396 
 397 
(iii) Travelling wave ion mobility spectrometry (TWIMS) is a novel method whereby ions are 398 
separated according to their mobility in a series of voltage pulses in a travelling wave (T-wave) 399 
mobility cell utilising RF ion guides (Gerlich, 1993). The resolving power is relatively low; 400 
however, collision cross-sections can be derived by calibration with known standards. This ion 401 
mobility approach has been successfully interfaced to a conventional time of flight mass 402 
spectrometer and, due to the trapping gates and fast data acquisition rate of the TOF, good 403 
sensitivity is achieved. Despite attempts (Shvartsburg and Smith, 2008; Smith et al., 2009a) 404 
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the motion of ions in TWIMS is not fully understood and TWIMS calibration is typically used to 405 
calculate CCS values. The commercial technical and software support has arguably 406 
reinforced attempts to utilise IMS-MS in separation, characterization and measurement 407 
applications, for example, via the routine use of multidimensional data in Driftscope software 408 
(Williams et al., 2009a) and software to process complex data such as time-aligned parallel 409 
fragmentation (D’Agostino and Chenier, 2010).  410 
 411 
In travelling wave ion mobility spectrometry a transient DC voltage pulse is applied in order to 412 
create an electromotive force via a series of sequentially opposite polarity RF-only rings to 413 
create a travelling wave which propels ions through the device, as shown in Figure 10. Ions 414 
with high ion mobility slip behind the wave less often (or spend more time surfing) than ions of 415 
low ion mobility thus enabling separation based on relative ion mobility. 416 
 417 
FIGURE 10.  Illustration of a stacked ring ion guide used in traveling wave ion mobility spectrometry 418 
(TWIMS), adapted from Pringle et al. (2007). 419 
 420 
Visualising data obtained using the proprietary Driftscope software enables a range of options 421 
for understanding the data including 3D visualisation, 2D plots and intensity views etc, The 422 
data can be interactively processed if desired, for example, to show data that only contains a 423 
certain component using various geometric selection tools such as lasso and square area.  424 
 425 
 426 
(iv) The Differential Mobility Analyser (DMA) was originally developed to generate particles in 427 
order to calibrate aerosol instruments, later expanded to describe the mobility of non-diffusing 428 
particles by Knutson and Whitby (1975) and recently to describe the mobility of diffusing 429 
particles by Stolzenberg & McMurray (2008). The DMA consists of a combination of electric 430 
field mobility in addition to a fast gas stream, only ions with a well defined electrical mobility 431 
are transmitted into an outlet slit leading to the mass spectrometer inlet (see Figure 11). The 432 
DMA vacuum regime means that the measured ions do not experience a vacuum interface or 433 
ion guide so may be less prone to structural modifications (Hogan et al., 2011) and, as the 434 
separation technique is a space-dispersion rather than a time-dispersion technique, the ions 435 
can be continuously transmitted to a mass spectrometer.  436 
 437 
 438 
 439 
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 440 
FIGURE 11. Schematic of the operation of a differential mobility analyzer. Ion are injected at the top 441 
left and move downwards and to the right, over a distance S, under the influence of an electric field E, 442 
adapted from de la Mora et al., (2006) 443 
The DMA technique may be considered a hybrid of DT-IMS and DMS as the separation 444 
process is based on the low electric field mobility like DT-IMS, however the sampling is 445 
continuous as in DMS. DMA-MS has been most widely explored for large molecules; however, 446 
discussion on multiple charged polyethylene glycol ions (Ude et al. 2004) illuminated 447 
structures from approximately 300 Da to 3000 Da describing configurations for long straight 448 
chain molecules. One of the advantages of DMA is that it can, theoretically, be easily added 449 
to existing mass spectrometry stages without complex interfaces due to operation at 450 
atmospheric pressure (Rus et al., 2010). A DMA was coupled to an existing Sciex QStar MS 451 
(Concord, ON, Canada) enabling separation of L-alanine and an isomer, sarcosine, 452 
(Martínez-Lozano P et al., 2010) which are proposed to be small molecule biomarkers from 453 
urine in the progress of prostate cancer.  454 
 455 
IMS covers a range of different techniques and unfortunately some gross simplifications have resulted 456 
in terminology that may be confusing.  457 
1. DTIMS is also known as Classical IMS, Conventional IMS, Standard IMS, Drift-Tube IMS, Time of 458 
flight IMS, Traditional IMS, Plasma Chromatography and Ion Chromatography. 459 
2. DMS includes High Field Asymmetric Waveform IMS (FAIMS), Field Ion Spectrometry and Ion 460 
mobility Spectroscopy and is commercialised in the Ionalytics Selectra, Thermo FAIMS, Owlstone 461 
Nanotechnologies and AB Sciex Selectra systems. 462 
3. Travelling wave ion mobility spectrometry (TWIMS) is commercialised in the Waters Synapt 463 
systems.  464 
4. Differential Mobility Analysers (DMA) have been developed by several groups at Yale (USA), 465 
CIEMAT (Madrid) and RAMEM (Madrid). 466 
 467 
Comparison of key benefits and challenges of IMS-MS methods 468 
There is currently a wealth of IMS-MS systems available both commercially and being used and 469 
developed in academic institutions.  470 
 471 
DT-IMS-MS has been most widely used in academic institutions and provided some of the highest 472 
resolving powers. An advantage of DT-IMS-MS is that the ion mobility can be determined 473 
experimentally and collision cross section determined without requiring calibration. A key challenge is 474 
that the pulsed analysis leads to an inherent loss of duty cycle and hence reduction in sensitivity.  475 
 476 
An advantage of both DMS-MS and FAIMS-MS is that it operates as a continuous device when the 477 
compensation voltage is selected so does not have the ‘lossy’ sampling issues of DT-IMS and TWIMS. 478 
The separation appears to be orthogonal to m/z and sometimes size so that separations may be 479 
uniquely tuned to select a chosen analyte and thus be used as a powerful separation technique. A 480 
key challenge is that it has proven difficult to definitively assign structural properties and changes to 481 
DMS measurements as several factors appear to contribute to the clustering/declustering mechanism 482 
and analyte drift times thus it appears to be best utilized as a separation device. 483 
 484 
An advantage of TWIMS-MS is that it is commercially supported and that the ion mobility can be 485 
determined experimentally and collision cross-section determined with suitable calibration. Whilst the 486 
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resolution obtained in TWIMS is typically lower than dedicated DT-IMS-MS and some FAIMS/DMS 487 
the software to interpret and process the complex data is well supported. 488 
 489 
Advantages of DMA-MS include operation in the low electric field regime that typically means less 490 
structural distortions and determination of collision cross-section, a continuous sampling rate that 491 
should mitigate sensitivity losses (with reported transmission efficiencies of up to 50% (Martínez-492 
Lozano et al., 2011)) and the theoretical ability to add the device as a front-end to many existing mass 493 
spectrometer systems. However DMA-MS has not been fully commercialized yet or utilized for the 494 
multitude of “small molecule” applications explored in DT-IMS-MS, FAIMS-MS, DMS-MS and TWIMS-495 
MS though it shows significant promise. 496 
C. Understanding IMS-MS resolving power and selectivity 497 
IMS can separate analytes based on their ion mobility including closely related species such as 498 
isomers (Williams et al., 2010), isobars and isotopomers (Shvartsburg et al., 2010a). The key 499 
parameters affecting a useful separation are 1) the resolving power and 2) the selectivity.   500 
 501 
Resolution and peak capacity in IMS 502 
The combination of ion mobility and mass spectrometry in IMS-MS offers a technique that is able to 503 
distinguish components based on their size to charge ratio (Ω/z for IMS) and mass to charge ratio 504 
(m/z for MS), thereby enabling orthogonal specificity.  Even with expensive high-resolution mass 505 
spectrometer systems affording m/∆m50% resolution of over 400,000 it is still analytically challenging to 506 
differentiate between isomeric components and often complex MSn experiments are required to 507 
achieve selectivity for unambiguous assignment. Ion mobility can provide extra resolving power, 508 
however IMS used alone is currently unable to unambiguously identify an unknown molecular 509 
component without a priori knowledge of the measured drift time. 510 
 511 
It is possible to measure the resolving power of ion mobility using a single quotient definition (Siems 512 
et al., 1994): 513 
  (6)  
514 
  515 
where R is the resolving power of the IMS, dt is the drift time of the ion of interest and wh is the full 516 
peak width measured at half height. Resolving power is a measure of the efficiency of an instrument 517 
to separate two peaks. The Waters Synapt G2 IMS system has been developed to encompass a 518 
resolving power of up to 40; FAIMS resolving powers of up to 100 (Shvartsburg et al., 2010b) have 519 
been achieved, and several reports of resolving powers of up to 225 with DT-IMS  have been reported 520 
(Koeniger et al., 2006; Shelimov et al., 1997; Kemper et al., 2009). Developments including higher 521 
pressure trapping and focussing (Clowers et al., 2008), overtone ion-mobility (Valentine et al., 2009) 522 
and circular instruments (Bohrer et al., 2008) are expected to exceed these current limitations.   523 
 524 
The number of theoretical plates is a mathematical concept, relevant in any chromatographic 525 
technique, which is often used to describe column efficiency and is an indirect measure of the peak 526 
width for a peak at a specific retention time: 527 
 528 
(7)  
529 
 
 530 
 531 
 532 
where N = number of plates, tR  = retention time and Wh = peak width at half height (in units of time). 533 
The number of theoretical plates is typically used to compare chromatographic systems and the data 534 
in Table 2 compares various types of IMS with typical traditional chromatographic techniques. 535 
 536 
TABLE 2.  A comparison of required resolving power in theoretical plates for various types of IMS 537 
compared to typical chromatographic conditions. 538 
 539 
Approximate number 
of theoretical plates 
Required 
resolving power 
of equivalent 
Comparative chromatography conditions 
whdtR /
2
545.5  hRWtN
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IMS 
20000 60 High performance liquid chromatography (HPLC) 
80000 120 Ultra high performance liquid chromatography 
(UHPLC) 
125000 150 Gas chromatography (GC) 
222000 200 High resolution IMS (Asbury & Hill, 2000a) 
887000 400 Capillary electrophoresis (CE) 
 540 
Therefore, a current high-resolution IMS resolving power of 200 is roughly equivalent to a 541 
chromatographic efficiency of >200,000 theoretical plates.  542 
 543 
Peak capacity of IMS-MS 544 
Complex samples require high efficiency to achieve separation and, even in early stage drug 545 
discovery, having a high efficiency affords a good opportunity to separate degradants and process 546 
impurities away from the desired product. Peak capacity is defined as the maximum number of peaks 547 
that can fit in any two-dimensional method (Ruotolo et al., 2002a). A two-dimensional method will 548 
have a high peak capacity if the resolution of each dimension is high and the difference in their 549 
separation mechanism (orthogonality) is high. The peak capacity will also be defined by the 550 
complexity of the sample and the properties of the analytes in the sample. For example, complex 551 
biological samples with a range of retention times will provide larger peak capacities for a technique 552 
than that of the analysis of a mixture of analytes of a specific class.  Peak capacity is therefore a 553 
better, but highly molecule dependent, indicator of the separation power compared to measuring 554 
resolution alone. 555 
 556 
In an ideal situation the peak capacity of a two-dimensional method is the product of the first and 557 
second dimensions (Li et al., 2009), but corrections can be made for cases where the two dimensions 558 
are not 100% orthogonal. Whilst the separation based on their size to charge ratio (Ω/z for IMS) and 559 
mass to charge (m/z for MS) ratio is, to some extent, orthogonal there is a well-known correlation 560 
between mobility ( size) and mass (Griffin et al., 1973), as illustrated in Figure 12.  561 
  562 
FIGURE 12.  Published mass mobility curves showing correlation between reduced mobility and mass 563 
within classes, but poor correlation in heterogeneous sets, adapted from Griffin et al. (1973). 564 
  565 
Therefore the corrected peak capacity, Pc, in IMS-MS can theoretically be estimated (Dwivedi et al., 566 
2010) using the relationship: 567 
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 568 
                                                     fraction of orthogonality  (8) 569 
 570 
where RIMS is the average resolving power of the ion mobility spectrometer, and RMS is the average 571 
resolution of the mass spectrometer.  572 
 573 
An example of increased peak capacity in IMS-MS was observed in a study of various classes of 574 
metabolites in blood (Dwivedi et al., 2010) including amino acids, organic acids, fatty acids, purines 575 
etc) using a DT-IMS-MS system. In the mass range of 23 – 830 m/z, the drift time spread of               576 
~14.3 ms results in ~28% of the total 2D space, or an average deviation in drift time of ±14% along 577 
the theoretical trend. With an average IMS resolving power of 90, average MS resolution of 1500, and 578 
±14% orthogonality, the estimated peak capacity, Pc, for the instrument is 90 x 1500 x 14% = 18,900.  579 
The relatively low MS resolution of 1500 (peak width is 0.27 Da at an average mass value of 404 m/z) 580 
in this study (Dwivedi et al., 2010) resulted in an estimated peak capacity of MS alone of 2989. A six 581 
fold increase in the peak capacity was therefore observed (~19,000) in IMS-MS compared to MS 582 
alone (~3000).  583 
Reverse phase chromatographic columns are routinely used to separate small molecules and the 584 
peak capacity for gradient elution high performance liquid chromatography was found to be typically 585 
up to 300 (Guo et al., 2009), and up to 400 (Wren, 2005) for gradient elution ultra-performance liquid 586 
chromatography. Comparing the peak capacity for different types of IMS with typical traditional 587 
chromatography peak capacities (Table 3) shows that the extra dimension of IMS is potentially a 588 
powerful separation tool.  589 
 590 
TABLE 3.  Approximate separation peak capacity for various analytical separation methods*.  591 
Technique Approximate peak capacity 
FAIMS 8.9 -44 (Canterbury et al., 2008)(Schneider et al., 2010b) 
DT-IMS 90 (Dwivedi et al., 2010)  
HPLC 300 (Guo et al., 2009)  
UHPLC 400 (Wren, 2005)  
MS 3000 (Dwivedi et al., 2010) 
IMS-MS 19000 (Dwivedi et al., 2010)  
LC-MS 900000 
LC-IMS-MS 11340000 (Dwivedi et al., 2010) 
*Ion mobility and hyphenated techniques are italicized                                        592 
 593 
It is conceivable that LC-IMS-MS may become a standard addition or replacement for LC-MS systems 594 
due to the ease of configuration and the increase in separating power. Indeed many proteomic 595 
applications are increasingly using LC-IMS-MS to separate complex peptide mixtures, leading to 596 
unprecedented extensive proteome maps (Liu et al., 2007b; Taraszka et al., 2005). LC-IMS-MS often 597 
does not require careful configuration, demanding sampling rates and does not appear to suffer from 598 
robustness issues compared to many two-dimensional techniques such as LCxLC, GCxGC etc. 599 
 600 
Modifying selectivity in IMS 601 
The selectivity of ion mobility can be modified by increasing the electric field  in DT-IMS (Wu et al., 602 
1998), the use of covalent shift reagents (Fenn and McLean, 2008)  to derivatise or non-covalent shift 603 
reagents (Clowers and Hill, 2006; Howdle et al., 2009) to form complexes with analytes and effect a 604 
selective shift in ion mobility relative to coincident analytes, using drift gas modifiers (Fernández-605 
Maestre et al., 2010a) sometimes called clustering agents in DMS-MS (Schneider et al., 2010b)), by 606 
altering the composition of the drift gas (Matz et al., 2002) and by the use of different reagent gases in 607 
GC-IMS-MS (Eiceman et al., 1995). Currently there does not appear to be a consensus on useful and 608 
well characterised selectivity modifiers so method development is presently not fully predictable; 609 
however some of these changes are trivial and can be considered analogous to changing the 610 
stationary or mobile phases in liquid chromatography.  611 
 612 
The use of covalent shift reagents (Fenn and McLean, 2008), as shown in Figure 13 , effectively 613 
derivatises molecules, potentially creating lower density analogues of the precursor species with a 614 
marked increase in the collision cross-section relative to a smaller increase in mass. This is clearly 615 
 MSIMSc RRP
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illustrated by deviations to larger cross sections compared to the general trend in mass-mobility 616 
correlation for carbohydrates. Compared to the underivatised species it was reported that covalent 617 
derivatisation afforded three distinct advantages: (i) tuneability was increased for isobaric species 618 
difficult to identify and/or resolve by mass spectrometry alone, (ii) an enhanced sensitivity of 2x more 619 
signal intensity was observed and (iii) the derivatised species could be used as tags or fragment 620 
labels in CID and as IR active species in IRMPD studies.   621 
 622 
 623 
FIGURE 13.  Effect of derivatisation of carbohydrate species with boronic acid on CCS, adapted from 624 
Fenn and McLean (2008). 625 
 626 
For small molecules the effect of the dipole interaction is typically far more significant than for large 627 
molecules (>500 Da) so that using drift gas modifiers or mixtures can be a powerful method to alter 628 
selectivity (elution order of analytes). Indeed for small molecules such as amino acids the polarisabiity 629 
has been found to be a critical factor affecting separation of analytes, whereas in large molecules the 630 
collision cross section term dominates (Steiner et al., 2006). Thus for small molecules exploiting 631 
polarizability to probe structural details and maximize separation has immense future potential. 632 
 633 
An example of the potential of exploiting polarizability to separate analytes is given by the different 634 
slopes of calculated ion radii for iodoaniline and chloroaniline with different drift gases, helium (0.205 635 
x 10-24 cm3), argon (1.641 x 10-24 cm3) and carbon dioxide (2.911 x 10-24 cm3), indicating that it should 636 
be possible to separate any analytes with different slopes (Figure 14) by choosing an appropriate drift 637 
gas composition.  638 
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 639 
 640 
FIGURE 14.  Calculated ion radii as a function of drift gas polarizability, from Asbury & Hill, 2000c. 641 
 642 
The use of vapour modifiers added to the drift gas in planar DMS-MS has been widely explored (e.g. 643 
Levin et al., 2007 and Eiceman et al. 2004) , although the full mechanism of the interactions has not 644 
been elucidated enough to enable predictable separations in mixtures. Levin et al.  (2004) 645 
systematically examined the effect of various polar clustering agents and postulated strong effects 646 
due to hydrogen-bonding potential, electrostatic attraction, steric repulsion and energetically feasible 647 
conformations. A series ofpublications exploring the cluster/declustering (Krylov et al. 2002, Krylov et 648 
al. 2009, Schneider et al. 2010a, Schneider et al. 2010c, Coy et al. 2010) further explored the 649 
possibility of predicting analyte shifts in response to changes in drift gas modification and provide a 650 
powerful route to optimising separations.  651 
 652 
The ‘cluster/declustering effect’ that addition of vapour modifier induces appears to have dramatic 653 
effects on the peak capacity in a planar electrode configuration (Schneider et al., 2010b), improving 654 
the peak capacity for a 70 component mixture from 13 in pure nitrogen to 44 in 2-propanol doped 655 
nitrogen (see FIGURE 15), although this had the disadvantage that 10/70 components were depleted 656 
in intensity by 20-fold or more due to them having a lower proton affinity than the dopant.  657 
 658 
 Page 18 of 45 
 
 659 
FIGURE 15.  Separation of a 70-compound mixture with (A) nitrogen transport gas and (B) nitrogen 660 
with 1.5% 2-propanol in parallel plate FAIMS configuration, adapted from Schneider et al., (2010b).  661 
 662 
Changes to the temperature, composition (Beegle et al., 2001) and pressure of a single drift gas is 663 
commonly used to change selectivity and IMS gasses including nitrogen, air, helium, carbon dioxide 664 
and sulphur hexafluoride have been evaluated. The use of binary gas mixtures (Howdle et al., 2010), 665 
shown in Figure 16, results in excellent selectivity enhancements over single gas composition IMS 666 
separations and demonstrates that this selectivity is tunable by altering the binary gas composition. 667 
 668 
 669 
FIGURE 16.  Effect of drift gas composition on the ion mobility resolution of the drugs rosiglitazone 670 
and lamotrigine [M+H]+ ions in binary drift gas mixtures in TWIMS. The composition of the binary drift 671 
gas mixtures are represented by shaded bars indicating the percentage of each gas in the mixture 672 
(left hand axis). Resolving powers greater than 1.5 indicate full separation of components and this 673 
threshold is indicated by the dashed line at a resolution of 1.5. The resolution of lamotrigine and 674 
rosiglitazone is indicated by the right hand axis. Adapted from Howdle et al., (2010). 675 
 676 
IV. APPLICATIONS OF IMS AND IMS-MS SEPARATIONS IN SMALL 677 
MOLECULE ANALYSIS 678 
IMS has been investigated for the analysis of a wide range of small molecule applications including 679 
active pharmaceutical ingredients (Budimir et al., 2007; Karimi and Alizadeh, 2009; O’Donnell et al., 680 
2008; Wang et al., 2007) veterinary drugs (Jafari et al., 2007), metabolites (Alonso et al., 2008), 681 
pesticides (Jafari, 2006; Keller et al., 2006; Tuovinen et al., 2000), prescription and illicit drugs (Dussy 682 
et al., 2008; Lawrence, 1986), combinatorial libraries (Collins and Lee, 2001), autonomous health 683 
diagnostics (Zhao et al., 2010) and immunoassay detection (Pris et al., 2009; Snyder et al., 1996). 684 
Here we outline some highlights of small molecule analysis using IMS-MS systems. 685 
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A. Low abundance metabolite and small molecule identification using IMS-MS 686 
A novel use of LC-IMS-MS was demonstrated for a 5HT3 antagonist, ondansetron, and its aromatic 687 
hydroxyl isomeric metabolites (Dear et al., 2010) that are typically generated in vivo and in vitro. 688 
Using conventional UHPLC-MS-MS the unambiguous characterisation of the hydroxyl metabolites 689 
would not be possible as they can produce identical MS/MS spectra. Using UHPLC-MS in a biological 690 
matrix system ondansetron and metabolites display different retention times but could not be 691 
assigned without using purified standards as a reference. Using an IMS separation, shown in Figure 692 
17, and in silico methods the components were identified based on their ion mobility. For these 693 
components a low number of rotatable bonds are present so the computational method is rapid, 694 
interpretation of complex NMR spectra is not required and isolation or synthesis is unnecessary to 695 
create primary standards. In this case the identity of metabolites with smaller than 1 Å2 difference 696 
between their CCS was distinguished using a combination of Waters Synapt TWIMS by comparison 697 
with CCS values obtained using computational methods. 698 
 699 
FIGURE 17.  TWIMS ion mobility arrival time distributions for ondansetron and the 6-, 7- and              700 
8-hydroxyl metabolites, adapted from Dear et al., (2010). 701 
The subsequent use of product ion mobility as a tool for assignment of positional isomers (Cuyckens 702 
F et al., 2011)  was also demonstrated for both model compounds and a real-case example, 703 
emphasizing the possibilities of structural determination by both parent ion and product ion mobility 704 
where mass spectra alone appear indistinguishable and cannot be used to confidently assign a 705 
candidate structure. For example two different product ion mobilities for 11 ortho, meta and para 706 
substituted hydroxyl metabolites with a phenylethylamine substructure were sufficient to assign their 707 
structures.    708 
B. Rapid, portable and sensitive analysis using miniaturisation of IMS and IMS-MS 709 
One of the advantages of FAIMS is that it does not require complicated vacuum equipment or large 710 
analyser tubes, thus it may be easily hyphenated to a portable mass spectrometer system (Manard et 711 
al., 2010). Microfabricated FAIMS chips can increase the speed of separation by 100-10,000 times, 712 
filtering ions on the microsecond timescale enabling rapid monitoring of species at low level 713 
concentrations (Shvartsburg et al., 2009a). Whilst the current microfabricated FAIMS units, example 714 
shown in Figure 18, are more suited to distinguish compound classes than individual species the 715 
multichannel FAIMS electrodes enables integration with an air sampler, ionisation source and 716 
detector for applications such as gas analysis, chemical monitoring and autonomous health 717 
diagnostics (Zhao et al., 2010).  718 
 719 
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 720 
FIGURE 18. Illustration of the size of microfabricated FAIMS chip, courtesy of Owlstone 721 
Nanotechnologies and Pacific Northwest National Laboratory. 722 
C. Increased selectivity in ambient and surface analysis mass spectrometry using IMS-MS 723 
The direct and rapid analysis of substances using ambient ionisation mass spectrometry sources 724 
allows mass spectrometry data to be obtained with little or no sample preparation required for a 725 
variety of surfaces and matrices from tissue samples to intact tablet or liquid formulations. Application 726 
areas have included quantitative and qualitative measurements in pharmaceutical analysis, forensics, 727 
bioanalysis, in vivo imaging, proteomics etc. Whilst MALDI has been widely adopted in biological 728 
applications, for the analyses of biomolecules, there is currently a great deal of interest in ambient 729 
mass spectrometry approaches and there are now at least thirty methods documented (Weston, 730 
2010).  731 
 732 
The introduction of an additional IMS stage adds a further separation step to ambient mass 733 
spectrometry analysis without the need for rigorous sample preparation. Indeed for most surface 734 
analysis mass spectrometry methods the fact that the surface is sampled and ions are generated in a 735 
single step means that the only viable method of separation and selectivity before the mass detector 736 
is to use a gas-phase separation method such as IMS. This extra selectivity maybe particularly useful 737 
in imaging applications. In the case of the example of whole-body imaging of rats, the rats were dosed 738 
with 6 mg/kg iv with the anticancer drug vinblastine and the removal of interfering isobaric ions from 739 
endogenous lipids helps increase confidence in the MALDI imaging data (Jackson et al., 2007) by 740 
removing ‘false positives’ which, by mass spectrometry imaging alone, could be interpreted as 741 
containing a high concentration of the active drug, as shown in Figure 19. The extra dimension of 742 
separation could also prove useful in removing any matrix-related isobaric ions. The datasets from the 743 
Driftscope imaging platform were transferred to Biomap 3.7.5.5 for visualization enabling facile 744 
interpretation.  745 
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 746 
FIGURE 19 .  MALDI-IMS-MS image showing distribution of ions in whole-body sections and the 747 
arrow points to the area where specificity increased with application of IMS, adapted from Jackson et 748 
al., (2007). 749 
 750 
D. Chiral analysis using IMS-MS 751 
A chiral modifier at 10 ppm of (S)-(+)-2-butanol was added to the buffer gas and enantiomers of a       752 
ȕ-blocker, atenolol, were separated (Dwivedi et al., 2006), as shown in Figure 20. It is proposed that 753 
selective interactions occur in the gas-phase between the enantiomer ion and the chiral modifier, to 754 
temporarily form a diastereomeric pair, so that the mobilities of the enantiomers are altered and can 755 
be separated in time. Chiral ESI-DT-IMS-MS is now commercialised viathe Excellims Corp IMS-756 
quadrupole-MS system. A smaller, portable chiral IMS detector is now being developed by Excellims 757 
Corp for fast, on-site analysis including pesticide residues and environmental samples (Anon). The 758 
advantages of chiral IMS-MS compared to competing analytical techniques such as chiral SFC and 759 
chiral HPLC include rapid method development and high sensitivity, enabling rapid determination of 760 
enantiomeric excess (e.e.) for use in QA/QC environments or in broader applications including 761 
biomarker and metabolite identification.  762 
 763 
 764 
FIGURE 20.  DT-IMS-MS separation of atenolol enantiomers showing the superimposed spectrum of 765 
the R and S enantiomers (similar results obtained using racemic mixture, not shown). Adapted from 766 
Dwivedi et al., (2006). 767 
Chiral resolution using FAIMS-MS has also been reported for 6 pairs of amino acid enantiomers 768 
separated as metal-bound complexes of divalent metal ion with an L-form amino acid (Mie et al., 769 
 Page 22 of 45 
 
2007), shown in Figure 21. The method employed a range of additional divalent metal cations and 770 
reference amino acids. Screening with different metal cations and reference compounds compares 771 
favourably with chiral HPLC and SFC screening times and can be automated using automated 772 
sample preparation platforms.  773 
 774 
FIGURE 21.  Separation of D/L-valine as [Cu2+(l-Trp)2(D/L-Val)-H]+. (a) D-Val; (b) L-Val. Adapted from 775 
Mie et al., (2007) . 776 
An example of epimer separation where the diastereomers differ by only one chiral carbon, was 777 
achieved for betamethasone and dexamethasone (Campuzano et al., 2011). The separation of the 778 
two epimers correlated well with differences observed in the calculated B3LYP/6-31G++(d,p) 779 
electrostatic potential surface. Whilst baseline separation is achievable by HPLC (Arthur et al., 2004) 780 
the mass spectra of these compounds is very similar so the rapid separation and correlation with 781 
molecular modeling quickly identify this pair of compounds.  782 
E. Resolution of isobars and isomers in complex mixtures using IMS-MS 783 
Over 1100 metabolites were detected from methanolic extracts of 50 ul of blood samples including 784 
separation of over 300 isobaric/isomeric components, achieved without pre-concentration (Dwivedi et 785 
al., 2010), shown in Figure 22. The peak capacity compared tomass spectrometric analysis alone was 786 
increased by ~6 times and a broad range of metabolites were detected including lipids, carbohydrates, 787 
isoprenoids and estrogens. Interpretation of the data is further enabled by examining characteristic 788 
mobility-mass correlation data to identify similar classes of metabolites. In addition a reduction in the 789 
background noise due to selective ion filtering enabled detection and identification of low abundance 790 
components. 791 
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 792 
FIGURE 22. (a) Two-dimensional spectra of metabolic features measured in methanolic extract of 793 
human blood (b) a zoomed in region of the DT-IMS-MS spectrum illustrating peaks detected at the 794 
same nominal mass with different mobilities showing separation of isomers and isobars, adapted from 795 
Dwivedi et al., (2010). 796 
F. Real-time reaction monitoring and process monitoring using IMS-MS 797 
Reaction-monitoring in real-time has the potential to enable understanding of when reactions can be 798 
terminated at a suitable, rather than arbitrary, endpoint. By monitoring a process regularly throughout 799 
the reaction time knowledge may also be accrued of the reaction, intermediates and product 800 
formation that could not be understood by irregular, sparse sampling alone and enable optimization of 801 
experimental parameters via chemometrics. The products formed by deprotonation of 7-fluoro-6-802 
hydroxy-2-methylindole with sodium hydroxide were monitored by TWIMS-MS (Harry et al., 2011) and 803 
showed complementary and extra information from TWIMS-MS compared to MS alone with shape 804 
selectivity information obtained by sampling every several minutes over a timescale of several hours 805 
(Figure 23).  806 
 807 
 808 
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 809 
FIGURE 23.  MS and TWIMS-MS analysis of the reaction of 7-fluoro-6-hydroxy-2-methylindole 810 
following the addition of aqueous sodium hydroxide. Signal response versus time in minutes for m/z 811 
166 (monomer, I), m/z 311 (O-linked dimer, II), m/z 456 (O-linked trimer), m/z 601 (O-linked tetramer), 812 
m/z 746 (O-linked pentamer) and m/z 891 (O-linked hexamer) using (a) MS and (b) IM-MS. Adapted 813 
from Harry et al., (2011). 814 
G. Rapid resolution of carbohydrate isomers using IMS-MS 815 
Carbohydrate isomers including oligosaccharides are involved in numerous biological processes, 816 
such as cell-cell recognition and the development of embryos, but one of the main functions of 817 
carbohydrates is as oxidisable substrates in catabolism. However, to fully understand their different 818 
roles and functions we need to understand both the linkage type and anomeric configuration whilst 819 
dealing with the challenge that, for example, in a mixture of 16 D and L-aldohexoses and 8 D and L-820 
aldoses the total number of isomers with the same mass will be 96. The use of mass spectrometry as 821 
a tool is hindered by the similarity between fragmentation data obtained for different isomers; however 822 
purification and determination of purity by NMR requires interpretation time and larger amounts of 823 
material. Separation of the metal ion adducts of anomeric methyl glycoside isomers (MeMan, MeGal 824 
and MeGlc) and isomeric forms of reducing sugars (Dwivedi et al., 2007), branch isomers, and very 825 
closely related isomers varying at a single stereochemical position (Zhu et al., 2009) were addressed 826 
where MSn was not able to deliver solutions to the problem, as shown in Figure 24.  827 
 828 
FIGURE 24.  Two-dimensional DT-IMS-MS spectra of a mixture of methyl-Į and ȕ-D- 829 
galactopyranosides showing the separation (N2 drift gas) of the sodium adducts at m/z 217, adapted 830 
from Dwivedi et al. (2007). 831 
  832 
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H. Rapid analyte testing in complex drug formulations by IMS-MS 833 
The combination of IMS-MS with ambient ionisation mass spectrometry may enable rapid analysis for 834 
complex mixtures including drug formulations without laborious method development and 835 
consumables required by other separation methods such as 2D LC-MS etc.  836 
The complementary techniques of IMS and DART ambient ionisation operated separately has been 837 
demonstrated for AG-013736 in 1 mg Axitinib tablets (Likar et al., 2011), enabling a rapid analysis of 838 
AG-013736 in AG-013736 drug substances by DART ionisation and analysis of low-level limits for 839 
absence of the drug in placebo tablets by ion mobility spectrometry using a Model 400B IONSCAN-LS 840 
from Smiths Detection Scientific (Danbury, CT). 841 
Hyphenated ambient ionisation IMS-MS and nano-electrospray has been used to analyse: 842  pharmaceutical formulations including tablets and creams containing one or more of ranitidine, 843 
paracetamol, codeine, anastrozole chlorhexidine and a nicotine-containing skin patch (Weston et 844 
al., 2005) using DESI.  845  pharmaceutical formulations from tablets containing one or more of timolol, paroxetine, 846 
paracetamol and codeine using nano-electrospray ionisation (Budimir et al., 2007).  847  pharmaceutical formulations containing one or more of paracetomol, ephedrine, codeine and 848 
caffeine from non-bonded reversed-phase thin layer chromatography (RP-TLC) plates by 849 
desorption electrospray ionisation (DESI) (Harry et al., 2009). 850 
These examples demonstrate the wide applicability of analyses in various types of formulation 851 
illustrating that pre-treatment of samples is not required, rapid analyses can be conducted, whilst 852 
maintaining reproducible and robust results. 853 
I. Analysis of supramolecular complexes using IMS-MS 854 
The syntheses of supramolecular complexes that possess photo-optical properties are desired for 855 
solar energy capture and conversion, molecular machines, photochemical drugs and fluorescent-856 
based sensors.  857 
 858 
FIGURE 25.  Schematic of Cu2+(DAC)2+ (I), DAC-NO (II), and PPIX-RSE (III), adapted from Baker et 859 
al., (2005). 860 
DT-IMS-MS was used to probe the structures of bichromic complexes (Figure 25; Baker et al., 2005) 861 
in order to provide relevant data for sampling from in situ fluid data. Complementary data to 1H-NMR, 862 
x-ray crystallography and fluorescence measurements were obtained.  863 
For I the crystal structure agreed well with DFT structures and IMS-MS measurements, indicating that 864 
solid-state structures agreed well with gas-phase measurements. Only a single peak was observed in 865 
the ion mobilogram and calculation gave 161 Å2 as the CCS, compared to 166 Å2 ± 5 Å2 predicted 866 
from the DFT structure.  867 
For II DT-IMS-MS measurements indicated two conformers by observation of two main bands in the 868 
ion mobilogram, by comparison with computational data this suggested two major families of Up-Up 869 
and Up-Down configuration, as shown in FIGURE 6. The solution NMR data for II also suggested two 870 
conformers but the structures could not be unambiguously determined from the data.  871 
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 872 
FIGURE 26.  Examples of the two families predicted for (II + H)+. The Up-Down family is the lower 873 
energy family, the Up-Up family has both anthracenyl groups on the same side as the cyclam. 874 
Adapted from Baker et al., (2005). 875 
 876 
For III DT-IMS-MS measurements indicated two conformers which, in combination with DFT 877 
measurements indicated two compact structures, rather than folded structures, and correlated well 878 
with photophysical features including a bimodal fluorescent decay and a residual emission in steady-879 
state luminescence experiments. The proportion of the two conformers measured by IMS-MS, shown 880 
in Figure 27, agreed well with pre-exponential factors that indicated an approximate 80:20 ratio. 881 
 882 
FIGURE 57.   ATD for (III + H)+ obtained at 80 K. Two distinct peaks indicate two conformers of         883 
(III + H)+ are present, adapted from Baker et al., (2005). 884 
J. Hydration and desolvation of ligands and substrates 885 
In drug design it is important to consider water molecules particularly in two situations:  886 
(i) those water molecules that will be displaced during ligand binding in a receptor (Poornima  887 
       and Dean, 1995), and  888 
(ii) those water molecules that will be desolvated crossing the membrane environment. 889 
 890 
Water in binding pockets in a receptor can provide surprising entropic and enthalpic contributions to 891 
structure and binding affinities (Pace et al., 2004; Homans, 2007). If the key water binding sites and 892 
influence of ‘small molecule’ ligands are known it may be possible to use this information in medicinal 893 
drug design, or to predict static hydration sites. It may be especially important to consider bridging 894 
waters that link ligand to protein via an extended hydrogen bond network. 895 
 896 
Understanding membrane permeability is key to drug delivery and activity and is typically understood 897 
by hydrogen bond descriptors such as polar surface area (PSA) and surrogate measurements such 898 
as logD. These are considered important physicochemical parameters and modulated during lead 899 
optimisation. The reason that these parameters are important is that it is polar groups that are most 900 
involved in desolvation when molecules move from an aqueous extracellular environment to the 901 
lipophilic membrane environment. During this migration molecules may change their conformation 902 
and lose water molecules in order to cross the membrane barrier. To further understand the effect of 903 
desolvation on ligands it is possible to add/remove water molecules one by one by changing the water 904 
vapour pressure of the DT-IMS-MS cell and gradually ascertain the ion mobility and conformation 905 
adopted from a hydrated towards a non-hydrated ion, shown in Figure 28(a). By measuring the 906 
energy change at different temperatures a van’t Hoff plot can be generated, shown in Figure 28(b), 907 
thereby revealing the entropic and enthalpic contributions to hydration.  908 
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 909 
 
                     (a)  
                                          (b) 
FIGURE 28.  (a) ATDs of hydrated phenyl acetylene ions (PWn) obtained following the injection of the 910 
phenyl acetylene ion (C8H6+) into 0.34 Torr of water vapor at 249 K (b) Van’t Hoff plots for the 911 
equilbria C8H6+(H2O)n-1 + H2O   C8H6+(H2O)n for n-1 and n as indicated. Adapted from Momoh & 912 
El-Shall., (2008). 913 
 914 
Hydration of small molecules has been studied for the phenyl acetylene ion, with stepwise hydration 915 
energies of 39.7 ± 6.3 kJ mol-1 from n=1 to 7; the entropy change for step 7 is larger, indicating a 916 
cyclic or cage like water structure (Momoh & El-Shall, 2008).  For the benzene ion stepwise hydration 917 
energies were 35.6 kJ mol-1 from n=1 to 6. The binding energies were larger in the n=7 and 8 clusters 918 
indicating cyclic or cage like water structures (Ibrahim et al., 2005). For small protonated peptides the 919 
hydration energy is largest for highly charged peptides and small non-arginine containing peptide and 920 
typically 30 to 60 kJ mol-1 (Wyttenbach et al., 2003); for pentapeptides AARAA, AARAA-OMe and Ac-921 
AARAA the binding energies were typically ~41 kJ mol-1. 922 
 923 
The foregoing IMS-MS studies indicate hydration/desolvation studies of small molecule ions can 924 
provide structural information in the gas phase, this may be relevant to:  925 
1) understanding water and hydrogen bonded networks (including their entropic consequences) 926 
involving protein, ligand and water as part of molecular recognition systems,  927 
2) ligand desolvation on transport through membrane environments, and 928 
3) hydrogen/deuterium exchange experiments and how they are effected by molecular 929 
conformation. 930 
 931 
Other methods to measure the hydration of small drug-like molecules include infra-red data recorded 932 
from a hydrated electrospray source or a droplet ion source (Poully et al., 2008) but these have not 933 
always provided unambiguous data, possibly due to the lack of energy required for proton transfer. 934 
The measurement of hydration/desolvation energies, described above, may provide a unique insight 935 
into the energy landscape of hydration/desolvation by conducting measurements over a range of 936 
temperatures. 937 
V. OVERVIEW OF COLLISION CROSS-SECTION (CCS) MEASUREMENTS FOR SMALL 938 
MOLECULES  939 
 940 
In DT-IMS-MS and TWIMS-MS, larger ions (with a larger CCS) tend to migrate slower through the 941 
gaseous medium in the IMS cell compared to smaller ions due to a higher number of collisions with 942 
the gas molecules (typically an inert gas such as nitrogen). The drift times through the IMS cell can 943 
also reveal structural information such as size, shape and topology; potentially including information 944 
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relating to accessible conformations. Unfortunately DMS and FAIMS are, currently, not suitable for 945 
carrying out CCS measurements. 946 
 947 
Understanding small molecule structure in the gas-phase may be advantageous for quality control or 948 
for a more detailed understanding of molecular structure in the gas-phase. For example in drug 949 
discovery the physicochemical and binding properties of small molecules depend on their 3D 950 
structure and at physiologically relevant temperatures a conformationally flexible small molecule is 951 
expected to be able to access a number of energetically feasible conformers, an example is shown in 952 
Figure 29. The timescale of interconversion of conformers will define the structural information that 953 
can be obtained in solution and in the gas-phase. Understanding the energetics of small molecule 954 
conformers is currently largely carried out by generating potential conformers, known as 955 
conformational sampling, in computational studies (Foloppe & Chen, 2009).  956 
 957 
FIGURE 29.  Hypothetical example of a one-dimensional molecular conformational potential energy 958 
surface. Conformational degrees of freedom (R) are shown on the X axis. Adapted from Foloppe & 959 
Chen (2009). 960 
 961 
Computationally sampled models have been compared with x-ray crystallographic structures to 962 
understand how well the conformer models correlate with the bioactive conformation. Solution NMR 963 
can provide valuable information about the 3D structure; however the interpretation is often difficult 964 
due to the exchange between several conformations and typically requires molecular modelling to 965 
interpret results. 966 
 967 
Rapid calculation of CCS by IMS-MS may be useful to decide which molecules in a library (series) 968 
could provide the optimum activity. This could be achieved coarsely by excluding molecules which are 969 
too rigid/flexible or too big/small as suggested by Williams et al. (2009a). These experiments 970 
potentially have the advantage of rapid speed of experiment and low consumption of sample relative 971 
to NMR and x-ray techniques. Understanding the conformation in the gas-phase may be a good 972 
indicator of the bioactive conformation.  This may be especially relevant to compounds in drug 973 
discovery which are challenging to isolate and characterise their structure. Mapping the 974 
conformational landscape defined via stereo-centres, intramolecular cyclisation etc., may help 975 
uncover a path to identification of new target compounds. 976 
 977 
For protein structures there is now significant evidence that the gas-phase protein structure can 978 
reflect the native state solution phase structure under certain carefully controlled conditions. There 979 
have been several publications that demonstrate a good correlation between x-ray, NMR and IMS 980 
studies for protein structures (Heck and van den Heuvel, 2004; Rand et al., 2009; Ruotolo et al., 2005; 981 
Schultz and Solomon, 1961; Shelimov et al., 1997; Shelimov and Jarrold, 1997), although there have 982 
also been some differences noted (Jurneczko and Barran, 2011).  However for small molecular 983 
weight molecules the evidence that gas-phase structures are similar to solution phase structures has 984 
been questioned; in a protein there are multiple cooperative interactions that maintain the 3D 985 
structure whereas for a small molecule there are typically fewer interactions resulting in a more 986 
flexible structure. Furthermore Allen et al. (1996) compared a range of gas-phase and x-ray molecular 987 
substructures for small molecules and suggested that high-energy conformers were represented more 988 
in gas-phase, room-temperature Boltzmann distributions than in crystal structures and broad peaks 989 
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observed in IMS have generally been interpreted as indicating that multiple conformations are 990 
accessible and interconvert on the IMS measurement timescale. 991 
 992 
Measurements using IMS-MS may not be the same as NMR (which are subject to solvent effects) or 993 
x-ray (which are subject to crystal lattice effects). In enzymes and membrane receptors, biomolecular 994 
recognition processes are likely to take place in hydrophobic ‘binding pockets’ of proteins where there 995 
will then be several interactions for a ligand including hydrophobic amino acids, with a large possibility 996 
(>0.8) of excluding most water molecules. The dielectric constant of a partial vacuum in IMS-MS (c.f. 997 
İvacuum = 1) is more similar to the immediate environment of a membrane receptor (İpeptide/protein = 2–4) 998 than for water (İwater = 80)(Bastug and Kuyucak, 2003). We may therefore postulate that the 999 
environment of a bioactive conformer will often be intermediate between aqueous and gas-phase 1000 
(vacuum). Therefore the gas phase may be an appropriate medium in which to study the ‘small 1001 
molecule’ structures which in their active form are bound to a receptor located in a membrane, rather 1002 
than in solution.  1003 
A. CASE STUDIES OF COLLISION CROSS-SECTION (CCS) MEASUREMENTS FOR SMALL 1004 
MOLECULES 1005 
1. Study of an organoruthenium complex and its adducts with a DNA oligonucelotide 1006 
TWIMS-MS has been used to understand the binding of a “piano-stool” shaped organoruthenium 1007 
complex with a single stranded oligonucleotide hexamer that show promise as an anti-cancer agent. 1008 
The illustration in Figure 30 shows examples of the protonated and deprotonated complexes, the 1009 
doubly positive charged complex and the doubly negative charged complex. The single peak (A) 1010 
suggests a single species, whereas multiple peaks in (B), (C) and (D) suggest either multiple binding 1011 
of the Ru-drug fragment (confirmed by interpretation of the mass spectra collected) or different 1012 
conformers present in the mononucleotide due to different charge distributions along the phosphate 1013 
backbone (Williams et al., 2009a).  1014 
 1015 
(E) 
 
  1016 
FIGURE 30.  Arrival time distributions (ATDs) or drift times for (A) the [M+2H]2+ ion of d(CACGTG); (B) 1017 
the [M-2H]2- ion of d(CACGTG); (C) the complex [CACGTG+2[(Ș6-bip)Ru(en)]-2H]2+; and (D) the 1018 
complex [CACGTG+2[(Ș6-bip)Ru(en)]-6H]2- and (E) structure of the organoruthenium anticancer 1019 
complex ([(Ș6-bip)Ru(en)]), adapted from Williams et al., (2009a). 1020 
The CCS values obtained for the Ru-based drug correlated well with those obtained by x-ray 1021 
crystallographic data so that binding could be easily identified. Using MS/MS experiments, shown in 1022 
Figure 31, subsequent to IMS separation, enabled the binding site to be determined by examining the 1023 
resulting fragmentation pattern.  1024 
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 1025 
FIGURE 31.  MS/MS spectrum of the precursor ion of m/z 807.5, corresponding to [CACGTG+2[(Ș6-1026 
bip)Ru(en)] H]3+. Inset shows the relevant sequence-specific ions detected. (Note: M represents 1027 
CACGTG), adapted from Williams et al., (2009a). 1028 
2. Study of the in-flight epimerisation of a bis-Tröger base 1029 
The epimerisation pathway via the proposed alternatives of a) a proton catalysed ring opening or b) 1030 
retro-Diels-Alder of a bis-Tröger base, shown in Figure 32, were investigated using TWIMS-MS 1031 
(Révész et al., 2011) as this could be important for the design of Tröger bases which, with their 1032 
tweezer type structure, have been suggested as useful agents as molecular receptors, chiral solvating 1033 
agents and inclusion complexes (Maitra et al., 1995). 1034 
 1035 
 1036 
FIGURE 32.  Proposed mechanism for epimerisation of a Tröger base by a) a proton catalysed ring 1037 
opening or b) a retro-Diels-Alder mechanism, Révész et al., (2011). 1038 
 1039 
The two structures were separated well in the gas-phase TWIMS stage (FIGURE 33) and activation of 1040 
ions pre-TWIMS separation and post-TWIMS separation demonstrated that the anti-1H+ isomer is the 1041 
most thermodynamically favoured by measuring the intensity of each parent ion. The preferred 1042 
mechanism was also concluded to be the proton catalysed ring opening as demonstrated by the lack 1043 
of epimerisation when a Na+ Tröger base was used as a surrogate proton-like participant in the 1044 
reaction, thus eliminating the possibility of a retro-Diels-Alder mechanism. 1045 
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 1046 
 1047 
FIGURE 33. Ion mobility trace with associated mass spectra (shown inset) of the anti- and                1048 
syn- isomers. The computationally calculated structures are shown above, adapted from Révész et al., 1049 
(2011). 1050 
B. Measurement of collision cross-section (CCS) for small molecules using DT-IMS-MS 1051 
The measurement of CCS in DT-IMS is simplified by the use of a static, uniform, electric field in which 1052 
ion motion takes place; the physical principles are established and mobility values can be used to 1053 
derive the collision cross-section. Knowing the length of the drift region and the time that ions take to 1054 
traverse it enables the ion’s velocity to be determined:  1055 
 1056 
(9)
 1057 
 1058 
 1059 
 1060 
where v is the ion’s velocity, K is the ion mobility constant, E is the electric field, L is the length of the 1061 
drift tube, td is the arrival time and V is the voltage across the drift region. 1062 
 1063 
K should be corrected for temperature and pressure to obtain the reduced ion mobility, K0 (corrected 1064 
to 273 K and 760 Torr): 1065 
 1066 
(10) 
1067 
 
 1068 
 1069 
 1070 
The collision cross-section, ΩT, can then be derived directly: 1071 
 1072 
(11)  
1073 
 
 1074 
 1075 
where Ω is the collision cross-section, ze is the ionic charge, N is the background gas number density, 1076 
ȝ is the reduced mass of the ion-neutral pair, k
  
is Boltzmann’s constant, T is the gas temperature and  1077 
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K is the mobility constant.   1078 
C. Calculation of collision cross-section (CCS) for small molecules using TWIMS 1079 
The measurement of CCS in TWIMS is not typically directly derived from the mobility of an ion (Giles 1080 
et al., 2010) as the motion of the analyte in the travelling wave regime is complicated and, to date, is 1081 
not fully understood. The TWIMS system is, therefore, usually calibrated using ions that have 1082 
previously been measured by employing DT-IMS. A typical calibration regime (Knapman et al., 2010) 1083 
has been described based on the CCSs of oligo-glycine ions (available at 1084 
http://www.indiana.edu/~clemmer/) which are currently accepted to be suitable as they are high 1085 
mobility ions in the expected mobility range of small molecules, and have been measured previously 1086 
using DT-IMS. Calibration with a static 4 V wave gave more drift time values over a narrower range of 1087 
CCSs than a wave ramp, potentially resulting in greater resolving power. Although changes can be 1088 
made to the buffer gas used in the measurement, the larger the buffer gas molecules, the larger the 1089 
CCS and it was noted that the buffer gas radius used in theoretical calculations must be indicative of 1090 
the buffer gas used in the original DT-IMS measurements (typically helium), even if the analysis of 1091 
calibrants and analytes is carried out in a different buffer gas.  1092 
 1093 
The experimental resolving power was reported under these conditions for the isomeric amino acids 1094 
isoleucine and leucine (131 Da), calculated the CCS at 68.95 Å2 and 70.51 Å2, respectively from the 1095 
measured arrival time distributions (see Figure 34). 1096 
.  1097 
 1098 
FIGURE 64.  Overlaid mobility chromatograms of L-Ile (open) and L-Leu (filled) acquired using a static 1099 
4 V wave height. The ESI-TWIMS-MS experimental CCS values measured were 68.95 and 70.51Å2, 1100 
and the calculated CCS values were 70.81 and 72.03Å2, for L-Ile and L-Leu, respectively. Adapted 1101 
from Knapman et al., (2010). 1102 
To understand the differences between solution state and gas-phase measurements the theoretical 1103 
collision cross-sections were calculated as a weighted average over multiple solution-phase rotameric 1104 
states from a database of 5000 protein structures and compared to the experimentally measured gas-1105 
phase values (Table 4). Calculated CCS values for hydrophobic amino acids gave the best 1106 
agreement with gas-phase TWIMS values, whilst more polar residues are experimentally found to be 1107 
much smaller than calculated, mostly likely due to burying of polar and charged termini. The largest 1108 
differences also appear to be correlated to the degrees of freedom in the amino acid side-chain.  1109 
 1110 
TABLE 4.  Comparison of measured and predicted CCS values for seven amino acids, adapted from 1111 
Knapman et al., (2010). 1112 
 1113 
Amino 
acid 
Mw 
(Da) 
Rotamers TWIMS 
experimental 
CCS (Å2) 
CCS predicted 
from solution state 
(Å2) 
Difference 
(Å2) 
Notes 
Pro 115.12 2 62.43 63.16 0.73 Hydrophobic 
Val 117.15 3 64.81 64.82 0.01 Hydrophobic 
Leu 131.12 4 70.51 72.03 1.52 Hydrophobic 
Ile 131.12 4 68.95 70.81 1.86 Hydrophobic 
Asp 133.11 5 62.93 69.81 6.88 Polar 
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Gln 146.15 5 62.85 75.08 12.23 Polar 
Glu 147.13 7 63.35 76.69 13.34 Polar 
 1114 
 1115 
This demonstrates that IMS-MS can distinguish between subtle changes in shape e.g. differentiating 1116 
Leu and Ile and also has the potential to reveal structural information about the important interactions 1117 
present in the gas-phase such as the burial of the polar groups in the examples Gln and Glu. 1118 
D. Calculation of collision cross-section (CCS) for small molecules using overtone IMS-MS 1119 
Recently, overtone mobility spectrometry (Kurulugama et al., 2009; Valentine et al., 2009), where 1120 
separation is achieved by applying time-dependent electric fields to sequential segments in a drift-1121 
tube thus eliminating ions that are not resonant with the applied field, has been used to demonstrate 1122 
measurements of ion collision cross-sections:  1123 
 1124 
(12)  
1125 
 
1126 
 1127 
where Ω is the collision cross-section, kb is the Boltzmann constant, z is the ionic charge, e is the 1128 
charge of an electron, N is the buffer gas density, T is the temperature of the buffer gas, P is the 1129 
pressure of the buffer gas, E is the electric field, mI and mB are the masses of the ion and the buffer 1130 
gas. The overtone IMS specific parameters include f which is the application frequency, h is the 1131 
harmonic index, It is the ion transmission length and Ie is the ejection length.  1132 
 1133 
Reduced ion mobilities are reported to enable a comparison of DT-IMS-MS and overtone-IMS-MS 1134 
measurements and are, in general, in good agreement. An especially interesting feature is the 1135 
potential for overtone-IMS-MS to exclude different ion structures i.e. with different ion mobilities in the 1136 
IMS stage. Typical IMS and TWIMS approaches are thought to measure an experimental average of 1137 
all structures sampled within the IMS drift time, whereas overtone-IMS-MS appears to enable 1138 
selection of particular structures over the IMS drift-time, potentially giving a better understanding of 1139 
transitions on the IMS measurement timescale, in the order of a few milliseconds. Current 1140 
measurements are limited for small molecules but development is ongoing. 1141 
E. Using theoretical calculations to understand ion mobility data 1142 
The assignment of structural information is typically made by comparing theoretical, calculated CCS 1143 
values with experimentally determined CCS values by using the following procedures: 1144 
 1145 
1. generate list of conformers, 1146 
2. minimise structures to lowest energy structures,  1147 
3. calculation of  theoretical CCS, and  1148 
4. comparison of  theoretical CCS values with experimentally determined values. 1149 
 1150 
1. Generate list of conformers 1151 
Initially the molecule must be transformed from a flat 2D to a representative 3D structure at 1152 
physiological pH taking into account tautomerism, likely protonation site(s), bond lengths etc. The 1153 
accessible conformations can be explored for small molecules (Dear et al., 2010; Williams et al., 1154 
2009b) using methods including systematic search, molecular dynamics, random search and grid 1155 
search tools but may be very computationally expensive if the number of rotatable bonds is high, 1156 
requiring evaluation of thousands of potential structures for relatively simple structures.  1157 
 1158 
2. Minimise structure to lowest energy structures  1159 
Molecular dynamics approaches have been applied to small molecules with success and 1160 
computationally are far less demanding than for large molecules (Baumketner et al., 2006; von 1161 
Helden et al., 1995; Hoaglund-Hyzer et al., 1999; Jarrold, 2000; Kinnear et al., 2002). Methods have 1162 
included force-field techniques including MMFF94 forcefield (Dear et al., 2010) and CHARM (Mao et 1163 
al., 2001) but quantum mechanical methods e.g., density functional theory (DFT) may also be feasible 1164 
for understanding small molecule structures. Indeed DFT has almost become the ‘norm’ for 1165 
        NTPllf hEmmTk ze etBIb 12.27376011111618 212121    
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calculating ion structures (Holmes et al., 1985), as it is more accurate than semi-empirical methods . 1166 
Recent work (Alex et al., 2009; Wright et al., 2010) has highlighted the potential for DFT to 1167 
understand electron density in bond formation/cleavage and the effect of protonation on bond lengths, 1168 
which makes DFT a potentially powerful tool in modelling ion structures in IMS-MS. Indeed the 1169 
information obtained from DFT calculations may contribute to a better understanding of the ion 1170 
structure for both the IMS separation and any tandem MS results. 1171 
 1172 
3. Calculation of theoretical CCS  1173 
The main calculation protocols for obtaining theoretical CCS values in IMS include projection 1174 
approximation (PA), trajectory method (TJ) and exact hard sphere scattering (EHSS). Whilst there has 1175 
been some debate about which type of modelling is most appropriate, it is generally recommended to 1176 
use the projection approximation (PA) method for small molecules of 20-100 atoms, for example 1177 
using the Sigma software package or MOBCAL software. However, PA typically underestimates 1178 
collision cross-sections for polyatomic species, especially for different surfaces including concave 1179 
structures, by up to 20% (Shvartsburg and Jarrold, 1996), so is not typically recommended for larger 1180 
molecular weight structures. 1181 
 1182 
TJ typically works well for any size system, but calculations are computationally expensive. Exact 1183 
Hard Sphere Scattering (EHSS) typically fails with small molecules because the ion-buffer gas 1184 
interaction becomes important compared to the geometry of the ion and careful calibration of the 1185 
relevant atomic radii is essential (Shvartsburg and Jarrold, 1996). EHSS and TJ appear to provide 1186 
better agreement for larger molecular weight ions as the parameterisation of EHSS is based on 1187 
fullerenes and other large molecular weight ions. 1188 
 1189 
There have been attempts to improve modelling, for large molecules (Shvartsburg et al., 2007) and 1190 
small molecules (Knapman et al., 2010; Siu et al., 2010), by construction of new parameter basis sets 1191 
with values for the carbon, oxygen, helium and nitrogen interaction radius calculated from suitable 1192 
representative molecules. Further development of modelling and prediction techniques (Fernandez-1193 
Lima et al., 2009) and improvement in parameter basis sets may well provide closer agreement 1194 
between calculated and measured CCSs. Recent improvements to a nitrogen based trajectory 1195 
method (Campuzano et al. 2011) may help understand data generated in N2(g) (as the less polarizable 1196 
He(g) is typically used)  and create better calibrations for collision cross sections (especially useful in 1197 
TWIMS where N2(g)  is the typical drift gas). The set of collision cross sections for pharmaceutically 1198 relevant ‘small molecule’ compounds appears self consistent (R2 = 0.9949) and covers a useful range 1199 
of 124.5 to 254.3 Å2 for nitrogen gas and a range of 63.0 to 178.8 Å2 for helium gas.   1200 
 1201 
4. Comparison of calculated CCS values with experimentally determined values 1202 
Typically validation is best achieved using known standards within experimental sets, either for 1203 
relative ranking of results or to increase confidence in measurements. Structure co-ordination sets are 1204 
widely available for some species e.g. at the RCSB Protein Data Bank and have been data based by 1205 
Clemmer (available at 1206 
http://www.indiana.edu/%7eclemmer/Research/cross%20section%20database/Proteins/protein_cs.ht1207 
m). However, it should be noted that the co-ordination structures from different sources may not agree 1208 
as NMR structures are often subject to solvent effects, x-ray structures subject to crystal lattice effects 1209 
and measurements by ion mobility may be subject to gas-phase neutral contamination, ionisation and 1210 
solvent effects. Some publications describe the calculation of theoretical collision-cross sections using 1211 
datasets obtained from NMR and x-ray files (e.g. PDB files) as input without subsequent energy 1212 
minimisation in the gas-phase which could result in erroneous estimates of CCS and further 1213 
assignment; in such a case a better understanding via structure/energy minimisation may be 1214 
important. 1215 
VI. PREDICTION OF ION MOBILITY CONSTANTS  1216 
Whilst many approaches to IMS explicitly use or attempt to derive information on the 3D structure of 1217 
the ion another approach is to use molecular descriptors to adequately describe an ion and predict 1218 
the reduced mobility without any requirement to carry out computationally expensive geometry 1219 
optimisation.  A quantitative structure property relationship (QSPR) methodology using five 1220 
descriptors for a training set of 70 organic compounds and excluding three outliers gave a multi-linear 1221 
regression (MLR) of R2 = 0.98 and s = 0.047; the test set of seven compounds gave s = 0.047 1222 
(Wessel and Jurs, 1994). Later, using six molecular descriptors on a training set of 135 compounds 1223 
and testing the model with 18 compounds gave an RMS error of 0.038 (Wessel et al., 1996). A more 1224 
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diverse set of 182 compounds and modification of two of the descriptors correlated with an R2 =0.80 1225 
(Agbonkonkon et al., 2004). A subset of 159 of that data set was used to develop linear and non-1226 
linear models using MLR and progression pursuit regression to achieve R2 values of 0.908 and 0.938 1227 
and s = 0.066 and 0.055, respectively (Liu et al., 2007a). The recent formulation of a linear equation 1228 
for ion mobility in a series of polar aliphatic organic compounds resulted in ion mobility predictions that 1229 
were typically >99% accurate (Hariharan et al., 2010). 1230 
 1231 
These molecular descriptor approaches are now widely used in predicting peptide IMS-MS drift times 1232 
(Wang et al., 2010) to improve confidence in peptide identification. The same approach to prediction 1233 
of ‘small molecule’ IMS-MS drift times could well help refine models of drift time prediction and better 1234 
understand important interactions affecting drift time and thus gas-phase structures, however this is 1235 
currently not well understood. 1236 
VII. FUTURE DEVELOPMENTS 1237 
The adoption of IMS-MS both for small molecule as well as large molecule applications is likely to 1238 
continue strongly, assisted by rapid developments in IMS design that marries the two stages of IMS 1239 
and MS and mitigates the challenges of ion efficiency and resolution that has hindered their 1240 
combination.  1241 
 1242 
The resistive glass-IMS design recently invented to replace the traditional stacked-ring ion guides 1243 
enables easier construction (Kwasnik and Fernández, 2010) and designs include a segmented rf 1244 
quadrupole in the vacuum interface that improve sensitivity by over 2 order of magnitude (Kaplan et 1245 
al., 2010). The inverse ion mobility spectrometry technique that applies an inverted pulse to the 1246 
shutter grid appears to increase resolution by 30-60% presumably by creating a gap in the charge 1247 
cloud and thus reducing space-charging effects (Tabrizchi and Jazan, 2010).  1248 
 1249 
A further hyphenation of a photoelectron spectrometer to a IMS-TOFMS shows promise as a 1250 
complementary method to obtain further information on the structures of gas-phase ions by obtaining 1251 
photoelectron spectra at three different detachment laser wavelengths (Vonderach et al., 2011), and 1252 
also hints at the possibilities for further information-rich data to be acquired and combined with IMS-1253 
MS by further hypenation. 1254 
 1255 
The adoption of IMS in hyphenated IMS-MS systems is continuing with important developments, for 1256 
example, Agilent previously announced collaborations with Owlstone Nanotechnologies for an IMS-1257 
MS system and Bruker have investigated new modes of IMS (Baykut et al., 2009). There have been 1258 
long-term research investments demonstrated in the launch of the second generation Waters Synapt 1259 
G2 IMS-MS with improved resolution and ion transmission and with the AB Sciex SelexION 1260 
technology that is available for the AB Sciex Triple Quad 5500 and QTRAP 5500 Systems including 1261 
selection of gas-phase dopants which can improve IMS separation and rapid 25 ms cycle time per 1262 
MRM which matches cycle times with multi-component analysis and UHPLC time scales.  1263 
 1264 
VIII. CONCLUSIONS 1265 
Whilst IMS is a ubiquitous technique in airports as well as military and forensic applications, it is still 1266 
the case that using IMS-MS for measuring structural information and for separations in ‘small 1267 
molecule’ applications there are subtle differences that can significantly affect the mobility and there is 1268 
much more to be understood about how to measure the structures of gas-phase ions reliably, the 1269 
nature of the fundamental intra-molecular interactions that define the structures and what the effect of 1270 
ion-neutral interactions are on ion mobility.  1271 
 1272 
Many chemical classes have been investigated using IMS and IMS-MS and some of the main 1273 
publications are listed in Table 5 to direct the reader to more detail on those classes. 1274 
TABLE 5.  Applications of IMS-MS and IMS to ‘small molecule’ classes. 1275 
 1276 
Class Year 
Hydrocarbons (Creaser et al., 2004) 1973 
Halogenated benzenes and nitro benzenes (o-, m-substituted) (Karpas et al., 1988)  1973 
Dihalogenated benzenes (o-, m-substituted) (Karpas et al., 1988) 1974 
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Benzoic and isophthalic and phthalic acids (Karpas et al., 1988) 1975 
Some sec-butylcholorodiphenyl oxides (Karpas et al., 1988) 1976 
o- and p- substituted chlorodiphenyl oxides (Karpas et al., 1988) 1976 
Ethyl butyl esters of maleic and fumaric  (Karpas et al., 1988) 1982 
Succinic acids  (Karpas et al., 1988) 1982 
Isomeric ketones 2-octanone vs. 4,4-dimethyl-3-hexanone  (Karpas et al., 1988) 1986 
Isomeric alcohols 1-octanol vs. 2-octanol   (Karpas et al., 1988) 1986 
Substituted electrophilic olefins, keto enol isomers, 2 keto and 2 enol (Karpas et al., 1988) 1988 
Amides and amines (Karpas et al., 1988) (Karpas et al., 1994)  1989 & 
1994 
Anilines (Karpas et al., 1990b)  1990 
Simple monocyclic and dicyclic compounds (Karpas et al., 1990a) 1990 
Aminoazoles (Karpas and Tironi, 1991) 1991 
Ketones (Karpas, 1991) 1991 
Aminoalcohols (Karpas, 1992) 1991 
Benzodiazepines, amphetamines and opiates  (Karpas et al., 1988) 2001 & 
2002 
Amino acids (Asbury & Hill, 2000b) 2001 
Amphetamines (Matz and Hill, 2002) 2002 
 1277 
Standardized calibration and measurement methods (Fernández-Maestre et al., 2010b), easily 1278 
implemented and accurate predictive models and interpretation of results are still being developed but 1279 
show great promise. The interchange between academia, vendors and industry is ensuring more 1280 
options are available to potential users of IMS-MS. A range of current commercial manufacturers and 1281 
IMS-MS types are listed in Table 6 for reference. 1282 
TABLE 6.  Commercially available IMS systems, or accessories able to interface to MS systems. 1283 
IMS-MS manufacturer Type 
Excellims IMS-MS DT-IMS 
Tofwerk IMS-MS DT-IMS 
Waters Synapt IMS-MS TWIMS 
Thermo FAIMS cylindrical electrode FAIMS 
Owlstone Nanotech FAIMS 
AB Sciex SelexION parallel plate DMS 
Sionex microDMx  DMS 
 1284 
Over the last decade there have been many novel applications and developments in IMS-MS 1285 
involving new methods to generate ions, accumulate and focus ions, select ions preferentially, 1286 
measure and process the multiplexed information and they have been used to solve problems ranging 1287 
from hydration/desolvation in ‘small’ organic molecules to understanding the fundamental interactions 1288 
in the building blocks of life, amino acids. IMS-MS is a novel method that can separate ions and use 1289 
information on their mobility to assign structure on an unparalleled rapid timeframe and at high levels 1290 
of sensitivity. In combination with a range of analytical equipment including ionisation sources, 1291 
separation devices, solution chemistry and gas-phase chemistry; the use of IMS-MS offers a versatile 1292 
and powerful approach to unique insights into complex mixtures and hitherto ambiguous structures. 1293 
 1294 
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